Logo
Login
$GEHC
$71.98 +$0.53 (0.74%) Close

Company Executives

$GEHC Management Team

Ms. Jeannette Bankes

Chief Executive Officer - Patient Care Solutions

Age -
Compensation -
Sex Female

Mr. Philip Rackliffe

President and CEO - Advanced Visualization Solutions

Age 51
Compensation -
Sex Male

Mr. Adam Holton

Chief People Officer

Age 54
Compensation -
Sex Male

Dr. Taha Kass - Hout

Chief Science and Technology Officer

Age 53
Compensation $5.719M USD
Sex Male

Mr. Roland Rott

President and CEO - Imaging

Age 53
Compensation $3.925M USD
Sex Male

Mr. James Saccaro

Chief Financial Officer

Vice President

Age 52
Compensation $5.671M USD
Sex Male

Mr. Frank Jimenez

General Counsel

Corporate Secretary

Age 60
Compensation $5.403M USD
Sex Male

Mr. Kenneth Stacherski

Chief Global Supply Chain and Service Officer

Age 54
Compensation -
Sex Male

Mr. H. Lawrence Culp

Chairman of the Board

Age 62
Compensation $454.9K USD
Sex Male

Mr. Peter Arduini

President

Chief Executive Officer

Director

Age 60
Compensation $19.49M USD
Sex Male

Mr. Kevin O'Neill

Chief Executive Officer - Pharmaceutical Diagnostics

Age 56
Compensation -
Sex Male

Board of Directors

From the proxy statement filed Mar 19, 2026
Directors
9
serving now
Independent
6 of 6
stated in the proxy; 3 not stated
Average tenure
2.0 years
from year joined
CEO also chairs the board
No
H. Lawrence Culp, Jr.
Director Age On board Independent Committees Other public boards Pay Source
H. Lawrence Culp, Jr.
Board chair
 62 Not stated Independent None stated GE Aerospace Not stated
Peter J. Arduini
CEO
 61 Not stated Not stated None stated Bristol Myers Squibb Paid as CEO
Rodney F. Hochman
70 Not stated Independent
Compensation Committee Governance Committee
None stated Not stated
Catherine Lesjak
67 2022
4 years
 Independent
Audit Committee · Chair
GE Aerospace Not stated
Kevin A. Lobo
60 2026
0 years
 Independent None stated Stryker, Parker-Hannifin Not stated
Anne T. Madden
61 Not stated Independent None stated None stated Not stated
Phoebe L. Yang
56 Not stated Independent None stated None stated Not stated
Risa Lavizzo‑Mourey Leaving at the meeting
Not stated Not stated Not stated None stated None stated Not stated
Tomislav Mihaljevic Leaving at the meeting
Not stated Not stated Not stated None stated None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

2 disclosed in the proxy filed Mar 19, 2026
Cleveland Clinic Foundation
Dr. Mihaljevic has served as the Chief Executive Officer and President, Morton L. Mandel CEO Chair, of Cleveland Clinic since 2018
Approximately $50 million
January 1, 2025 through February 28, 2026

GE HealthCare sold products and services to Cleveland Clinic Foundation and recognized revenue from them

With GE HealthCare Open in proxy
Providence
Dr. Hochman served as the President and Chief Executive Officer of Providence from 2016 through 2024
Approximately $61 million
January 1, 2025 through February 28, 2026

GE HealthCare sold products and services to Providence and recognized revenue from them

With GE HealthCare Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans